Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 J+Allergy+Clin+Immunol+Pract 2015 ; 3 (2): 152-61 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Biologics in Asthma ? The Next Step Towards Personalized Treatment #MMPMID25754716
Asthma is a multifaceted disease and is associated with significant impairment and risk, and a therapeutic response that is highly variable. While current treatments are usually effective for patients with mild to moderate disease, patients with more severe asthma are often unresponsive to current efforts, and there remains a need for agents with properties which may achieve control in these individuals. There is ongoing research to identify bioactive molecules that contribute to the pathophysiology of asthma, and many of these have been identified as potential therapeutic targets to improve control of this disease. As a consequence of these efforts, monoclonal antibodies have been developed and tested as to their effectiveness in the treatment of asthma. The assessment of these new treatments has identified particular pathways which, in selected patients, have shown benefit. The following review will discuss the current and future use of biological agents for the treatment of asthma, their efficacy, and how certain patient phenotypes and endotypes may be associated with biomarkers which may be used to select treatments to achieve greatest effectiveness of their use. As knowledge of the effects of these biological agents in asthma emerge, as well as the patients in whom they are most beneficial, the movement toward personalized treatment will follow.
free
free
free
J+Allergy+Clin+Immunol+Pract 2015 ; 3 (2): 152-61
